iNKT Cells: Clinical Trials

3 trials of iNKT Cells, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting, 1 unknown. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Completed 1, Recruiting 1, Unknown 1

Follow iNKT Cells: new trials by email Literature Review of iNKT Cells trials Research Report on iNKT Cells

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
GKL-006 Injection Plus TACE Versus TACE Alone in Patients With Unresectable Hepatocellular Carcinoma
GKL-006 Injection, TACE - Hepatocellular Carcinoma (HCC), Unresectable Hepatocellular Cancer
Phase 2RecruitingBeijing Gene Key Life Technology Co., Ltd482025-11-142026-08-17
Adoptive Autologous iNKT Cells for the Treatment of Progressed Hepatocellular Carcinoma Continuing on PD-1 Inhibitor Therapy
iNKT Cells, PD-1, Regorafenib - Hepatocellular Carcinoma
Phase 2UnknownBeijing YouAn Hospital842023-10-262024-01-16
Study of Adoptive Transfer of iNKT Cells Combined With TAE/TACE to Treat Unresectable HCC
iNKT cells, Human recombinated Interleukin-2, TAE/TACE - Hepatocellular Carcinoma
Phase 2CompletedBeijing YouAn Hospital602018-03-012024-10-08

Conditions studied

Carcinoma, Hepatocellular (3)

Sponsors

Beijing YouAn Hospital (2)  ·  Beijing Gene Key Life Technology Co., Ltd (1)

Countries

China (3)

Top investigators

Gaojun Teng, MD (1)  ·  Jun Lu, Director (1)  ·  Jun Lu, MD. (1)

Results publications

PMID 37637501